29.37 - È£¸£¸ó¡¤ÇÁ·Î½ºÅ¸±Û¶õµò¡¤Æ®·Òº¹»ê¡¤·ùÄÚÆ®¸®¿£(õ¿¬ÀÇ °Í°ú ÀÌ¿Í µ¿ÀÏÇÑ ±¸Á¶¸¦ °¡Áö´Â ÇÕ¼ºÀÇ °ÍÀ¸·Î ÇÑÁ¤ÇÑ´Ù), À̵éÀÇ À¯µµÃ¼¿Í ÀÌ¿Í À¯»çÇÑ ±¸Á¶¸¦ °¡Áö´Â °ÍÀ¸·Î¼ ÁַΠȣ¸£¸óÀ¸·Î »ç¿ëµÇ´Â °Í(º¯¼ºµÈ Æú¸®ÆéŸÀ̵å üÀÎÀ» °¡Áø °ÍÀ» Æ÷ÇÔÇÑ´Ù)
[È£Çؼ³] ÀÌ È£¿¡´Â ´ÙÀ½ °ÍÀ» Æ÷ÇÔÇÑ´Ù : (¥°) õ¿¬ È£¸£¸ó : »ç¶÷À̳ª µ¿¹°ÀÇ »ì¾ÆÀÖ´Â Á¶Á÷¿¡¼ »ý¼ºµÇ´Â È°¼º ¹°Áú·Î¼ ±ØÈ÷ ¼Ò·®À¸·Î ƯÁ¤ ±â°üÀÇ ±â´ÉÀ» ¾ïÁ¦Çϰųª ÀÚ±ØÇÑ´Ù. ±â°ü¿¡ Á÷Á¢ ÀÛ¿ëÇϰųª ÇÕ¼ºÀ» Á¶ÀýÇÏ°í 2Â÷ ȤÀº 3Â÷ È£¸£¸ó°èÀÇ ºÐºñ¿¡ °ü¿©ÇÑ´Ù. È£¸£¸óÀÇ ¼ºÁúÀ» ³ªÅ¸³»´Â ±âº»ÀûÀΠƯ¡Àº ¹ÝÀÀÀ» ÀÏÀ¸Å°±â À§Çؼ ½ºÅ×·¹¿À ºÐÀÚ ¼ö¿ëü(stereospecific molecular receptor)¿Í °áÇÕÇÑ´Ù´Â °ÍÀÌ´Ù. ÀÌ ¹°ÁúÀÇ ºÐºñ´Â º¸Åë ³»ºÐºñ¼±¿¡ ÀÇÇÏ¿© ±³°¨°è¿Í ºÎ±³°¨°è¿¡ ÀÇÇØ Áö¹èµÈ´Ù. È£¸£¸óÀº »ç¶÷À̳ª µ¿¹°Ã¼³»ÀÇ Ç÷¾×, ÀÓÆľ×À̳ª ±× ¹ÛÀÇ ¾×ü¿¡ ÀÇÇØ ¿î¹ÝµÈ´Ù. È£¸£¸óÀº ³»ºÐºñ¼±°ú ¿ÜºÐºñ¼±(exocrinal)À̳ª ¿©·¯ ¼¼Æ÷Á¶Á÷ Áß¿¡¼ »ý¼ºµÈ´Ù. Ç÷¾×À» ÅëÇÑ ¿î¹ÝÀÌ È£¸£¸óÀÇ ¹ÝÀÀÀ» À§ÇØ ÇʼöÀûÀÎ °Í¸¸Àº ¾Æ´Ï´Ù. ¹ÝÀÀÀº È£¸£¸óÀ» ¹æÃâ½ÃŲ ¼¼Æ÷ ¾ÈÀÇ ¼ö¿ëü[ÃøºÐºñ(ö°ÝÂù² : paracrine) Á¶Àý]³ª ¼¼Æ÷ À§ÀÇ ¼ö¿ëü(ÀÚ°¡ºÐºñ Á¶Àý)¿Í °áÇÕÇÏ¿© È£¸£¸óÀ» °£Áú ¾× ¾ÈÀ¸·Î ¹æÃâ½ÃÄ×À» ¶§µµ ³ªÅ¸³´Ù. (¥±) õ¿¬ ÇÁ·Î½ºÅ¸±Û¶õµò(prostaglandins)¡¤Æ®·Òº¹»ê(thromboxanes)°ú ·ùÄÚÆ®¸®¿£(leukotrienes) : ½Åü¿¡¼ ºÐºñµÇ´Â °ÍÀ¸·Î ±¹¼Ò È£¸£¸óÀ¸·Î ÀÛ¿ëÇÑ´Ù. ÇÁ·Î½ºÅ¸±Û¶õµò(prostaglandins)Àº È£¸£¸óÀ̳ª ÀÌ¿Í À¯»çÇÑ ¹°Áú·Î¼ ÇǺΠÁ¶Á÷¿¡ ÀÇÇؼ ÇÕ¼ºµÇ¸ç, ƯÁ¤ÇÑ ¼¼Æ÷ ¼ö¿ëü¸¦ °áÇÕ½ÃÅ°´Â ¿ªÇÒ(±¹¼ÒÀÇ ¼¼Æ÷ȯ°æ¿¡¼ ÀÛ¿ëÇÑ´Ù)°ú ¿©·¯ °¡ÁöÀÇ Á¶Á÷¿¡¼ ¼¼Æ÷È°µ¿ÀÇ Á¶ÀýÁ¦·Î¼ ÀÛ¿ëÇÑ´Ù. ÀÌ·¯ÇÑ ¼¼ Á¾·ùÀÇ ÈÇÐÀû ¹°Áúµé(¾Æ¶óÅ°µ·»êÀÇ À¯µµÃ¼)Àº "È£¸£¸ó°ú À¯»çÇÑ ÀÛ¿ë(hormone-like action)"À» ÇÏ´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. (¥²) ÇÕ¼º(»ý¹°°øÇÐÀûÀÎ °úÁ¤À» Æ÷ÇÔ)¿¡ ÀÇÇØ Àç»ýµÇ´Â õ¿¬ È£¸£¸ó¡¤ÇÁ·Î½ºÅ¸±Û¶õµò(prostaglandins)¡¤Æ®·Òº¹»ê(thromboxanes)°ú ·ùÄÚÆ®¸®¿£(leukotrienes) : ÀÌ°ÍÀº õ¿¬¹°Áú°ú °°Àº ÈÇб¸Á¶¸¦ °¡Áö°í ÀÖ´Ù. (¥³) õ¿¬À̳ª ÇÕ¼ºÈ£¸£¸óÀÇ À¯µµÃ¼, ÇÁ·Î½ºÅ¸±Û¶õµò¡¤Æ®·Òº¹»ê(thromboxanes)°ú ·ùÄÚÆ®¸®¿£[°¡·É ¿°¡¤ÇҷΰÕÈ À¯µµÃ¼¡¤°í¸®½Ä ¾Æ¼¼Å»¡¤¿¡½ºÅ׸£(esters) µî]°ú È¥ÇÕÀ¯µµÃ¼[ÇҷΰÕÈ À¯µµÃ¼ÀÇ ¿¡½ºÅ׸£(esters)] (ÁַΠȣ¸£¸óÀ¸·Î¼ »ç¿ëÇÏ´Â °æ¿ì·Î ÇÑÁ¤ÇÑ´Ù.) (¥´) È£¸£¸ó¡¤ÇÁ·Î½ºÅ¸±Û¶õµò¡¤Æ®·Òº¹»ê°ú ·ùÄÚÆ®¸®¿£ÀÇ À¯»çü : À¯»çü(analogues)¶ó´Â ¸»Àº ¸ðü ÇÕ¼º¹°°ú À¯»çÇÑ ±¸Á¶Àû °ü°è¸¦ °¡Áö´Â ÈÇй°ÁúÀ» ¸»ÇÏÁö¸¸ À¯µµÃ¼·Î °£ÁÖÇÏÁö´Â ¾Ê´Â´Ù. ±×°ÍÀº õ¿¬ ÇÕ¼º¹°°ú ±¸Á¶ÀûÀÎ À¯»ç¼ºÀ» °¡Áö´Â ÇÕ¼º¹°µéÀ» Æ÷ÇÔÇÏÁö¸¸ ´Ù¸¥ ¹°Áúµé¿¡ ÀÇÇØ ´ëüµÈ ±¸Á¶ ¾È¿¡´Â Çϳª³ª ±× ÀÌ»óÀÇ ¿øÀÚ¸¦ °¡Áø´Ù. (a) Æú¸®ÆéƼµå(polypeptide)ÀÇ È£¸£¸óÀÇ À¯»çü´Â õ¿¬ Æú¸®ÆéƼµå(polypeptide) °í¸® ¾È¿¡¼ ÷°¡¡¤ºÐ¸®¡¤´ëü¿Í ƯÁ¤ÇÑ ¾Æ¹Ì³ë»êÀÇ º¯È¸¦ ÅëÇØ Çü¼ºµÈ´Ù. ¼ºÀå È£¸£¸ó ¼Ò¸¶ÅäÆ®·ÎÇÉÀÇ À¯»çüÀÎ ¼Ò¸¶Æ®·½(somatrem)(INN)Àº ¾Æ¹Ì³ë»ê ¸»´ÜÀ» õ¿¬ ¼Ò¸¶ÅäÆ®·ÎÇÉ ºÐÀÚ¿¡ ÷°¡ÇÏ¿© Çü¼ºµÈ °á°ú¹°ÀÌ´Ù. õ¿¬ ¾Æ¸£±âÇÁ·¹½Å(INN)°ú ¸®ÇÁ·¹½Å(INN)ÀÇ À¯»çüÀÎ ¿À¸£´ÏÇÁ·¹½Å(ornipressin)(INN)Àº ¾Æ¸£±âÇÁ·¹½Å°ú ¸®ÇÁ·¹½Å ºÐÀÚ¿¡¼ ³»ºÎ ¾Æ¹Ì³ë»êÀ» ´ëüÇÏ¿© Çü¼ºµÈ °á°ú¹°ÀÌ´Ù. °í³ªµµ·¹¸°(gonadorelin)(INN)ÀÇ À¯»çüµéÀÎ ÇÕ¼º °í³ªµ¹¸®¹ö¸°¡¤ºÎ¼¼·¹¸°(buserelin)(INN)¡¤³ªÆÄ·¹¸°(nafarelin)(INN)¡¤ÆäÆ¿·¹¸°(fertirelin)(INN)¡¤·ùÇÁ·Î·¹¸°(leuprorelin)(INN)°ú ·çÆ®·¹¸°(lutrelin)(INN)Àº ƯÁ¤ÇÑ ¾Æ¹Ì³ë»êµéÀ» õ¿¬ °í³ªµµ·¹¸°(gonadorelin)ÀÇ Æú¸®ÆéƼµå(polypeptide) °í¸®¿¡¼ º¯È ½ÃÅ°°Å³ª ´ëüÇÑ °á°ú¹°ÀÌ´Ù. ÄÚ¸£Æ¼ÄÚ¸£µµÇÉ(INN)ÀÇ À¯»çüÀÎ ±â·ºÆ¼µå(giractide)(INN)´Â õ¿¬ ÄÚ¸£Æ¼ÄÚÆ®·ÎÇÉÀÇ ÃÖÃÊ 18°³ÀÇ ¾Æ¹Ì³ë»ê°ú °°Àº ±¸Á¶¸¦ °¡Áö°í ÀÖ´Ù. ·¾Æ¾(leptin)ÀÇ À¯»çüÀÎ ¸ÞÆ®·¹·¾Æ¾(metreleptin)(INN)Àº Àΰ£ ·¾Æ¾ÀÇ ÀçÁ¶ÇÕ ¸ÞƼ¿À´Ò À¯µµÃ¼ÀÌ´Ù. ¾ÈÁö¿ÀÅÙ½ÅIIÀÇ ºÐÀÚ¿Í ºñ±³Çؼ ¼¼ °¡Áö ´Ù¸¥ ¾Æ¹Ì³ë»êÀ» ÇÔÀ¯ÇÑ »ç¶ö¶ó½Å(saralasin)(INN)Àº ¾ÈŸ°í´Ï½ºÆ® È¿°ú(antagonist effects)¸¦ °¡Áö°í ÀÖ´Ù ÇÏ´õ¶óµµ ¾ÈÁö¿ÀÅÙ½ÅIIÀÇ ±¸Á¶Àû À¯»çü·Î °£ÁÖÇÏ¿©¾ß ÇÑ´Ù[ÀüÀÚ´Â °¾ÐÁ¦(hypotensor)À̸ç ÈÄÀÚ´Â ½Â¾ÐÁ¦(hypertensor)ÀÌ´Ù]. (b) ½ºÅ×·ÎÀ̵å È£¸£¸óÀÇ À¯»çü´Â ¸µ Ãà¼Ò³ª È®Àå¿¡ ÀÇÇØ È¤Àº ¸µ ¾È¿¡¼ ƯÁ¤ÇÑ ¿øÀÚµéÀ» ´Ù¸¥ ¹°Áúµé(ź¼Ò ÀÌ¿ÜÀÇ ¿øÀÚ)·Î ±³Ã¼ÇÔÀ¸·Î º¯ÇüµÉ ¼ö ÀÖ´Â °í³ ±¸Á¶(gonane structure)*¸¦ °¡Áö°í ÀÖ¾î¾ß ÇÑ´Ù. µµ¸ðÇÁ·¹ÀÌÆ®(domoprednate)(INN)¿Í ¿Á»êµå·Ñ·Ð(oxandrolone)(INN)Àº ÀÌ·± Á¾·ùÀÇ À¯»çüÀÇ µÎ °¡Áö ¿¹ÀÌ´Ù. ¾Õ¼ ¸»ÇÑ °í³(gonane)ÀÇ ±âº»ÀûÀÎ ±¸Á¶¸¦ À¯ÁöÇÏ´Â À¯»çü¿Í À¯µµÃ¼µéÀÇ Á·µéÀº È£¸£¸ó ¾ïÁ¦Á¦¿Í ±æÇ×Á¦·Î »ç¿ëÇÏ´Â »ó´çÈ÷ ¸¹Àº ¹°ÁúµéÀ» Æ÷ÇÔÇÑ´Ù. ¿¹·Î Ç׾ȵå·Î°ÕÀÎ ½ÃÇÁ·ÎÅ×·Ð(cyproterone)(INN)¡¤Ç×°í³ªµµÆ®·ÎÇÉÀÎ ´Ù³ªÁ¹(danazol)(NN)¡¤ÇÁ·Î°Ô½ºÅ×·Ð »ý»êÀ» ¾ïÁ¦ÇÏ´Â ¿¡Æ÷½ºÅº(epostane)(INN)ÀÌ ÀÖ´Ù. (c) ÇÁ·Î½ºÅ¸±Û¶õµòÀÇ À¯»çü¡¤Æ®·Òº¹»ê°ú ·ùÄÚÆ®¸®¿£µéÀº °í¸®¿¡¼ ¿øÀÚÀÇ Ä¡È¯À̳ª ¸µÀÇ Çü¼º°ú Á¦°Å¿¡ ÀÇÇØ Çü¼ºµÉ °ÍÀÌ´Ù. Æ¿¼öÇÁ·Î½ºÆ®(tilsuprost)(INN)¿¡¼ ÇÁ·Î½ºÅ¸±Û¶õµò À¯»çü¡¤»ê¼Ò¿Í ź¼Ò ¿øÀÚ´Â Áú¼Ò¿Í Ȳ ¿øÀڷΠġȯµÇ°í ÇϳªÀÇ ¸µÀº ´ÝÈ÷°Ô µÈ´Ù. (VI) È£¸£¸óÀÇ Ãµ¿¬ È¥ÇÕ¹°¡¤È£¸£¸ó À¯µµÃ¼³ª È£¸£¸ó È¿°ú¸¦ °¡Áö°í ÀÖ´Â °ÍÀ¸·Î ÀÎÁ¤µÇ´Â ½ºÅ×·ÎÀ̵åÀÇ Ãµ¿¬ È¥ÇÕ¹°(°¡·É ÄÚƼÄÚ½ºÅ×·ÎÀ̵å È£¸£¸ó°ú °áÇÕ ¿¡½ºÆ®·Î°ÕÀÇ Ãµ¿¬ È¥ÇÕ¹°)µµ Æ÷ÇԵdzª ÀÎÀ§ÀûÀΠȥÇÕ¹°À̳ª Á¶Á¦¹°Àº ¹èÁ¦µÈ´Ù(ÀϹÝÀûÀ¸·Î Á¦3003È£³ª 3004È£). È£¸£¸ó ¹æÃâÀÎÀÚ(È£¸£¸ó ÀÚ±ØÀÎÀÚ), È£¸£¸ó ¾ïÁ¦Á¦¿Í Ç×È£¸£¸óÁ¦ ¶ÇÇÑ ÀÌ È£¿¡ ºÐ·ùÇÑ´Ù(ÀÌ ·ùÀÇ ÁÖ Á¦8È£¸¦ ÂüÁ¶). ÀÌ È£¿¡´Â È£¸£¸óÀÇ À¯µµÃ¼ ȤÀº ±¸Á¶ÀûÀ¸·Î À¯»çÇÑ °Íµéµµ Æ÷ÇÔÇÑ´Ù. ´Ü ÀÌ °°Àº È£¸£¸óÀº õ¿¬ È£¸£¸ó¡¤ÇÕ¼º È£¸£¸ó¿¡ ±âº» Àç·á¸¦ µÎ¸ç È£¸£¸ó°ú ºñ½ÁÇÑ Ã¼°è¸¦ ÀÌ¿ëÇØ ÀÛ¿ëÇÏ´Â °æ¿ì·Î ÇÑÁ¤ÇÑ´Ù. ÀÌ È£¿¡ ÇØ´çÇÏ´Â ¹°Ç°À» ÈÇб¸Á¶¿¡ µû¶ó ¿°ÅÇÑ Ç°¸ñÇ¥´Â ´ÙÀ½°ú °°´Ù. ÀÌ ¸ñ·ÏÀº ÇØ´çÇÏ´Â ¹°Ç°À» ¸ðµÎ ¿°ÅÇÑ °ÍÀº ¾Æ´Ï´Ù. Á¦2937È£¿¡ ÇØ´çµÇ´Â ¹°Ç°À¸·Î ºÐ·ùÇÏ´Â Ç°¸ñÇ¥(*) (*) ¸íĪÀÌ ¼¼°èº¸°Ç±â±¸(WHO)¿¡¼ °øÇ¥ÇÑ International Nonproprietary Names ¶Ç´Â International Nonproprietary Names(Modified) for pharmaceutical substancesÀÎ °æ¿ì ±× ¸íĪÀ» ¸ÕÀú ±âÀçÇÏ°í °¢°¢(INN) ¶Ç´Â (INNM)À» Ç¥½ÃÇÏ¿´À½.(A) Æú¸®ÆéŸÀ̵å(polypeptide) È£¸£¸ó¡¤´Ü¹éÁú È£¸£¸ó°ú ±Û¸®ÄÚÇÁ·ÎÅ×ÀÎ(glycoprotein) È£¸£¸ó°ú ±× À¯µµÃ¼¿Í ±¸Á¶ÀûÀ¸·Î À¯»çÇÑ °Í ¿©±â¿¡´Â ƯÈ÷ ´ÙÀ½ÀÇ °ÍÀ» Æ÷ÇÔÇÑ´Ù. (1) ¼ºÀåÈ£¸£¸ó¡¤À̵éÀÇ À¯µµÃ¼¿Í ±¸Á¶ÀûÀÎ À¯»çü : ¼ºÀå È£¸£¸ó[¼ºÀå È£¸£¸ó, GH, STH(¼ºÀåÈ£¸£¸ó)] : Á¶Á÷üÀÇ ¼ºÀåÀ» ÃËÁø½ÃÅ°´Â ±×¸®°í ´Ü¹éÁú ½ÅÁø´ë»çÀÇ ´Ù¸¥ ¹ÝÀÀµéÀÇ Á¶Àý°ú °ü·ÃÀÌ ÀÖ´Â ¹°¿¡ ³ì´Â ´Ü¹éÁú¡¤³úÇϼöü Àü¿±ÀÇ ¼ºÀå¼¼Æ÷¿¡ ÀÇÇØ ºÐºñµÈ´Ù. ºÐºñ´Â ºÐºñ ¿ä¼Ò(¼ºÀåÈ£¸£¸ó-ºÐºñÈ£¸£¸ó)¿Í ¾ïÁ¦ ¿ä¼ÒÀÎ ¼Ò¸¶Å佺ŸÀÎ(¼ºÀå¾ïÁ¦È£¸£¸ó)¿¡ ÀÇÇØ Á¶ÀýµÈ´Ù. ¼ºÀåÈ£¸£¸ó(hGH)Àº 191°³ÀÇ ¾Æ¹Ì³ë»ê Áß ´ëºÎºÐ À¯ÀüÀÚ ÀçÁ¶ÇÕ DNA±â¼ú¿¡ ÀÇÇؼ¸¸ ¸¸µç ´Ü ÇϳªÀÇ Æú¸®ÆéƼµå(polypeptide) °í¸®ÀÌ´Ù. ÀÌ ºÎºÐÀº ¶ÇÇÑ À¯µµÃ¼¿Í ¼Ò¸¶Æ®·½(somatrem)(INN)(¸ÞƼ¿À´Ò hGH)¡¤¾Æ¼¼Æ¿È hGH¡¤Å»¾Æ¹Ì³ë hGH¿Í ¼Ò¸Þ³ëÆ÷¸£(somenopor)(INN)¿Í °°Àº À¯»çü¿Í Æä±×ºñ¼Ò¸ÕÆ®(INN)¿Í °°Àº È£¸£¸ó¹æÁöÁ¦(hormone antagonists)¸¦ Æ÷ÇÔÇÑ´Ù. (2) Àν¶¸°(insulin)°ú ±× ¿°(salts) : Àν¶¸°Àº 51°³ÀÇ ¾Æ¹Ì³ë»ê ±×·ìÀ» ÇÔÀ¯ÇÏ´Â Æú¸®ÆéƼµå(polypeptide)ÀÌ¸ç ¸¹Àº µ¿¹°µé ÃéÀåÀÇ ¶û°Ô¸£Çѽº¼¶(islets of Langerhans)¿¡¼ ¸¸µé¾îÁø´Ù. Àΰ£ÀÇ Àν¶¸°Àº ÀçÁ¶ÇÕµÈ Àΰ£ Àν¶¸°À» ¸¸µé±â À§ÇØ ÃéÀå¿¡¼ ÃßÃâÇϰųª ¼Ò³ª µÅÁöÀÇ Àν¶¸°À» º¯ÇüÇÔÀ¸·Î ȤÀº ¹ÚÅ׸®¾Æ³ª È¿¸ð¿Í °ü·ÃµÈ »ý¹°°øÇÐÀûÀÎ °úÁ¤µéÀ» ÅëÇØ ¾òÀ» ¼ö ÀÖ´Ù. Àν¶¸°Àº ¼øȯÇÏ´Â Æ÷µµ´ç°ú ±× ¹ÛÀÇ ¿µ¾ç¼Ò¸¦ ±Û¸®ÄÚ°Õ°ú Áö¹æ ÇüÅ·ΠÀúÀåÇÒ »Ó¸¸ ¾Æ´Ï¶ó ¼¼Æ÷ÁúÀÇ ±× ¼·Ãë¿¡ ÀÖ¾î ÇϳªÀÇ ¿ä¼ÒÀÌ´Ù. ¼ø¼ö Àν¶¸°Àº Èò»öÀÇ Èí½À¼ºÀÌ ¾ø´Â ºñ°áÁ¤ÁúÀÇ °¡·ç ȤÀº ¼ö¿ë¼ºÀÇ ±¤ÅÃÀÌ ÀÖ´Â °áÁ¤Ã¼ÀÌ´Ù. ÀÌ°ÍÀº ´ç´¢º´ Ä¡·á¿¡ ¾²ÀδÙ. Àν¶¸°¿°Àº ¿°»ê Àν¶¸°À» Æ÷ÇÔÇÑ´Ù. (3) ºÎ½ÅÇÇÁúÀÚ±ØÈ£¸£¸ó(corticotropin)(INN)[¾Æµå·¹³ëÄÚ¸£Æ¼ÄÚÆ®·ÎÇÈ È£¸£¸ó(ACTH : adreno corticotropic hormone)¡¤¾Æµå·¹³ëÄÚ¸£Æ¼ÄÚÆ®·ÎÇÉ] : ¹°¿¡ ³ì´Â Æú¸® ÆéŸÀ̵å·Î¼ ¾Æµå·¹³ëÄÚ¸£Æ¼Ä® ½ºÅ×·ÎÀ̵åÀÇ »ý¼ºÀ» ÀÚ±ØÇÑ´Ù. Áö·¢Æ¼µå(Giractide)(INN)µµ ºÎ½ÅÇÇÁúÀÚ±ØÈ£¸£¸óÀÇ À¯»ç¹°ÁúÀÌ´Ù. (4) À¯ÁóºÐºñÈ£¸£¸ó(lactogenic hormone : LTH¡¤°¥¶ôƾ¡¤°¥¶ôÅäÁø È£¸£¸ó¡¤·çÅ׿ÀÆ®·ÎÇÉ¡¤¸¶¸ðÆ®·ÎÇÉ¡¤ÇÁ·Î¶ôƾ) : °áÁ¤¼ºÀÇ Æú¸®ÆéŸÀ̵å(polypeptide)·Î¼ À¯ÁóºÐºñ(êáñðÝÂÝô : milk secretion)ÀÛ¿ëÀ» ÃËÁøÇÏ°í Ç×ü(corpus luteum)ÀÇ È°¼º¿¡ ¿µÇâÀ» ÁØ´Ù. (5) °©»ó¼±ÀÚ±ØÈ£¸£¸ó(thyrotrophin)(INN)(Ƽ·ÎÆ®·ÎÇÈ È£¸£¸ó¡¤TSH : thyroid-stimulating hormone) : Ç÷¾× ÁßÀÇ °©»ó¼± ÀÛ¿ë°ú ¿ä¿ÀµåÀÇ À̵¿¿¡ °ÔÀçÇÏ´Â ´ç´Ü¹éÁú(glycoprotein)ÀÌ´Ù. ¼ºÀå°ú ºÐºñ¿¡ ¿µÇâÀ» ¹ÌÄ£´Ù. (6) ³ÀÚÀÚ±ØÈ£¸£¸ó(follicle-stimulating hormone : FSH) : ´ç´Ü¹éÁúÀ¸·Î¼ ¹°¿¡ ³ìÀ¸¸ç ¼º±â´ÉÀ» ÀڱؽÃŲ´Ù. (7) ȲüÇü¼ºÈ£¸£¸ó[luteinising hormone : LH¡¤(Á¶Á÷ »çÀÌÀÇ ¼¼Æ÷ÀÚ±Ø È£¸£¸ó)(ICSH : interstitial-cell-stimulating hormone), ·çÅ×À̳뽺Ƽ¹Ä¸°] : ¼ö¿ë¼º±Û¸®ÄÚÇÁ·ÎÅ×ÀΡ¤½ºÅ×·ÎÀÌµå ºÐºñ¿Í ¹è¶õ°ú Á¶Á÷ »çÀÌÀÇ ¼¼Æ÷Çü¼ºÀ» ÃËÁøÇÏ¸é¼ ¼º±â´ÉÀ» ÀÚ±ØÇÑ´Ù. (8) À¶¸ð¸·(chorionic) °í³ªµµÆ®·ÎÇÉ(INN)(hCG : »ç¶÷ À¶¸ð¼º ¼º¼± ÀÚ±ØÈ£¸£¸ó) : ÅÂ¹Ý Áß¿¡¼ »ý¼ºµÇ´Â ´ç´Ü¹éÁú(glycoprotein)À¸·Î¼ ÀÓ»êºÎÀÇ ¼Òº¯¿¡¼ ÃßÃâµÈ´Ù. ¹é»ö °áÁ¤Ã¼·Î¼ ±× ¼ö¿ë¾×Àº ºÒ¾ÈÁ¤ÇÏ¸ç ³Æ÷ÀÇ ¼º¼÷À» ÀڱؽÃŲ´Ù. (9) Ç÷û°í³ªµµÆ®·ÎÇÉ(INN)(eCG : ¸»ÀÇ À¶¸ð¼º ¼º¼± ÀÚ±Ø È£¸£¸ó) : »ý½Ä¼± ÀÚ±ØÀÛ¿ëÀ» ÇÏ´Â ´ç´Ü¹éÁú(glycoprotein)À¸·Î¼ ÀÓ½ÅÇÑ ¸»ÀÇ Å¹ݰú Àڱ󻸷¿¡¼ »ý¼ºµÈ´Ù. º»·¡ ÀÓ½ÅÇÑ ¸»ÀÇ Ç÷û°í³ªµµÆ®·ÎÇÉÀ¸·Î ºÒ¸°´Ù. (10) ¿Á½ÃÅä½Å(oxytocin)(INN)[¾ËÆÄ(¥á)-È÷Æ÷ÆĹÎ] : Æú¸®ÆéŸÀ̵å(polypeptide)·Î¼ ¹°¿¡ ³ìÀ¸¸ç ÁÖ·Î Àڱà ¼öÃà°ú À¯¼±ÀÇ À¯ºÐÃâ ÀÛ¿ëÀ» ÇÑ´Ù. ¶ÇÇÑ Ä«¸£º£Åä½Å(carbetocin)(INN)¡¤µ¥¸ñ½ÃÅä½Å(demoxytocin)(INN) µîÀÇ À¯»ç ¹°Áúµµ Æ÷ÇÔÇÑ´Ù. (11) Ç÷°ü¼öÃàÈ£¸£¸ó(vasopressins) : ¾Æ¸£±âÇÁ·¹½Å(INN)°ú ¸®ÇÁ·¹½Å(INN)¡¤±× À¯µµÃ¼¿Í À¯»çÇÑ ±¸Á¶¸¦ °¡Áø ¹°Áú¡¤Ç÷°ü¼öÃàÈ£¸£¸óÀº Æú¸®ÆéŸÀ̵å(polypeptide)·Î¼ Ç÷¾Ð»ó½ÂÀÛ¿ë°ú ÄáÆÏÀÇ º¸¼ö·Â Áõ°¡ÀÛ¿ëÀ» ÇÑ´Ù. ¶ÇÇÑ Å׸£¸®ÇÁ·¹½Å(terlipressin)¡¤µ¥½º¸ðÇÁ·¹½Å(desmopressin)°ú °°Àº Æú¸®ÆéŸÀ̵å(polypeptide) À¯»ç¹°Áúµµ Æ÷ÇÔÇÑ´Ù. (12) Ä®½ÃÅä´Ñ(calcitonin)(INN)(TCA : Ƽ·ÎÄ®½ÃÅä´Ñ) : Æú¸®ÆéŸÀ̵å(polypeptide)·Î¼ Ç÷¾× Áß Æ÷µµ´çÀÇ ³óµµ¸¦ Áõ°¡½ÃÅ°´Â Ư¼ºÀÌ ÀÖ´Ù. (13) ±Û·çÄ«°ï(glucagon)(INN)(HGF : ÇÏÀÌÆÛ±Û¸®¼¼¹Í-±Û¸®ÄڰԳ븮ƽ ÀÎÀÚ) : Æú¸®ÆéŸÀ̵å·Î¼ Ç÷¾× Áß Æ÷µµ´çÀÇ ³óµµ¸¦ Áõ°¡½ÃÅ°´Â Ư¼ºÀÌ ÀÖ´Ù. (14) Ƽ·Ñ¸®º£¸°(thyroliberin)(TRF¡¤TRH) : Æú¸®ÆéŸÀ̵å·Î¼ Ƽ·ÎÆ®·ÎÇÉ(thyrotropin)ÀÇ ºÐºñ¸¦ ÀڱؽÃŲ´Ù. (15) °í³ªµµ·¼¸°(gonadorelin)(INN)(°í³ªµµ¸±º£¸°¡¤°í³ªµµÆ®·ÎÇÉ ÀÚ±ØÈ£¸£¸ó¡¤LRF¡¤GnRH) : Æú¸®ÆéŸÀ̵å·Î¼ ³úÇϼö¼±¿¡¼ ³Æ÷¿Í Ȳü ÀÚ±Ø È£¸£¸óÀÇ ºÐºñ¸¦ ÃËÁø½ÃŲ´Ù. ¶ÇÇÑ Æú¸®ÆéŸÀ̵å À¯»ç¹°Áú ºÎ¼¼¸±¸°(buserilin)¡¤°í¼¼¸±¸°(goserilin)¡¤Æ丣Ƽ·¼¸°(fertirelin)¡¤¼¼¸£¸ð·¼¸°(sermorelin) µîµµ Æ÷ÇÔÇÑ´Ù. (16) ¼Ò¸¶Å佺Ÿƾ(somatostatin)(INN)(SS¡¤SRIH¡¤SRIF) : Æú¸®ÆéŸÀ̵å·Î¼ ³úÇϼö¼±À¸·ÎºÎÅÍ ¼ºÀåÈ£¸£¸ó°ú TSHÀÇ ¹æÃâÀ» ¾ïÁ¦ÇÏ¸ç ½Å°æÄ£ÈÀÛ¿ëÀ» ÇÑ´Ù. (17) ½É¹æ¼º ³ªÆ®·ýÀÌ´¢ È£¸£¸ó(atrial natriuretic hormone : ANH¡¤ANF) : ½ÉÀåÀÇ ½É¹æ¿¡¼ºÎÅÍ ºÐºñµÇ´Â Æú¸®ÆéƼµå È£¸£¸óÀÌ´Ù. Ç÷¾×ÀÇ ºÎÇÇ°¡ Áõ°¡ÇÏ¿© ½ÉÀåÀÇ ½É¹æÀÌ È®ÀåµÉ ¶§ ANH°¡ ºÐºñµÇµµ·Ï ÀڱصȴÙ. ±× ´ÙÀ½ ANH´Â ¼Ò±Ý°ú ¹°ÀÇ ¹è¼³À» Áõ°¡½ÃÅ°°í Ç÷¾ÐÀ» °¨¼Ò½ÃŲ´Ù. (18) ¿£µµÅÚ¸°(endothelin) : ¸Æ°ü ±¸Á¶ Àüü¿¡ ÆÛÁ® ÀÖ´Â ³»ÇǼ¼Æ÷¿¡¼ ºÐºñµÇ´Â Æú¸®ÆéƼµå È£¸£¸óÀÌ´Ù. ¿£µµÅÚ¸°ÀÌ ¼øȯµÇ´Â Ç÷¾×À¸·Î ¹æÃâµÈ´Ù ÇÒÁö¶óµµ, ±×°ÍÀº ÃøºÐºñ(ö°ÝÂù² : paracrine) °æÇâ¿¡ ÀÇÇØ ÀÎÁ¢ÇÑ Ç÷°üÀÇ ÆòÈ°±ÙÀ» ¼öÃàÇϵµ·Ï ±×¸®°í Ç÷¾ÐÀ» Áõ°¡ ½ÃÅ°µµ·Ï ±¹ºÎÀûÀ¸·Î È°µ¿ÇÑ´Ù. (19) ÀÎÈ÷ºó(inhibin)°ú ¾×Ƽºó(activin) : »ý½Ä¼±(gonadal) Á¶Á÷¿¡¼ ¹ß°ßµÇ´Â È£¸£¸óÀÌ´Ù. (20) ·¾Æ¾(leptin) : Æú¸®ÆéŸÀ̵å È£¸£¸óÀ¸·Î¼ ³úÀÇ ¼ö¿ëü¿¡¼ ½Åü Áß·®°ú Áö¹æ ħÂøÀ» Á¶ÀýÇÏ´Â ¿ªÇÒÀ» ÇÏ´Â °ÍÀ¸·Î ¹Ï¾îÁö´Â Áö¹æ Á¶Á÷¿¡ ÀÇÇØ »ý»êµÈ´Ù. ¶ÇÇÑ ¿©±â¿¡´Â ·¾Æ¾ÀÇ ÀçÁ¶ÇÕ ¸ÞƼ¿À´Ò À¯µµÃ¼ÀÎ ¸ÞÆ®·¹·¾Æ¾(metreleptin)(INN)ÀÌ Æ÷ÇԵǴµ¥, ÀÌ´Â ·¾Æ¾ÀÇ À¯»çü·Î °£ÁÖÇÏ¸ç ·¾Æ¾°ú À¯»çÇÑ È°µ¿À» ÇÑ´Ù. (B) ½ºÅ×·ÎÀ̵å È£¸£¸ó¡¤±× À¯µµÃ¼¿Í ±¸Á¶Àû À¯»çü (1) ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀ̵å(corticosteroid) È£¸£¸ó : ºÎ½ÅÇÇÁúÀÇ ¿ÜÇÇ¿¡¼ ºÐºñµÇ¾î ÀÎüÀÇ ½ÅÁø´ë»ç¸¦ À§ÇØ Áß¿äÇÑ ¿ªÇÒÀ» ÇÑ´Ù. ±×°ÍµéÀº ºÎ½ÅÇÇÁú È£¸£¸ó°ú ÄÚ¸£Æ¼ÄÚÀ̵å¶ó°í ¾Ë·ÁÁ® ÀÖÀ¸¸ç ÀϹÝÀûÀ¸·Î ±×µéÀÇ »ý¸®Àû ÀÛ¿ë¿¡ µû¶ó µÎ ±×·ìÀ¸·Î ³ªÀ§¾îÁø´Ù. Áï (¥°) ´Ü¹éÁú°ú ź¼öȹ°ÀÇ ´ë»ç ÀÛ¿ëÀ» Á¶ÀýÇÏ´Â ´çÁú ºÎ½ÅÇÇÁú È£¸£¸ó°ú (¥±) ÀÎüÀÇ ³ªÆ®·ý°ú ¹°À» À¯ÁöÇÏ°í Ä®·ýÀÇ ¹è¼³ ÃËÁøÇÏ´Â ÀüÇØÁú ºÎ½ÅÇÇÁú È£¸£¸óÀÌ ÀÖ´Ù. ÀüÇØÁú ºÎ½ÅÇÇÁú È£¸£¸óÀÇ Æ¯Â¡Àº ¿¡µð½¼º´À̳ª ÄáÆÏ °áÇÌÀÇ Ä¡·á¿¡ ÀÌ¿ëµÈ´Ù. À̵éÀº ¾Æ·¡ÀÇ ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀ̵å È£¸£¸ó¡¤À¯µµÃ¼¿Í À¯»çüµéÀ» Æ÷ÇÔÇÑ´Ù. (a) ÄÚ¸£Æ¼¼Õ(cortisone)(INN)* : ´Ü¹éÁú°ú ź¼öȹ° ´ë»ç ÀÛ¿ëÀ» Á¶ÀýÇÏ°í ¶ÇÇÑ ±¹ºÎÀûÀÎ ¼Ò¿°ÀÛ¿ëÀ» ÇÏ´Â ´çÁú ºÎ½ÅÇÇÁú È£¸£¸ó (b) È÷µå·ÎÄÚ¸£Æ¼¼Õ(hydrocortisone)(INN)(ÄÚ¸£Æ¼Á¹)* : ÄÚ¸£Æ¼¼Õ°ú À¯»çÇÑ ÀÛ¿ëÀ» ÇÏ´Â ´çÁú ºÎ½ÅÇÇÁú È£¸£¸ó (c) ÇÁ·¹µå´Ï¼Õ(prednisone)(INN)(Å»È÷µå·ÎÄÚ¸£Æ¼¼Õ) : ´çÁú ºÎ½ÅÇÇÁú È£¸£¸ó¡¤ÄÚ¸£Æ¼¼ÕÀÇ À¯µµÃ¼. (d) ÇÁ·¹µå´Ï¼Ö·Ð(prednisolone)(INN)(Å»È÷µå·ÎÈ÷µå·ÎÄÚ¸£Æ¼¼Õ) : ´çÁú ¼ö½ÅÇÇÁú È£¸£¸ó¡¤È÷µå·ÎÄÚ¸£Æ¼¼ÕÀÇ À¯µµÃ¼ (e) ¾Ëµµ½ºÅ×·Ð(aldosterone)(INN) : ÀüÇØÁú ºÎ½ÅÇÇÁú È£¸£¸ó (f) ÄÚ¸£Å䵶¼Õ(cortodoxone)(INN) ¸î¸î À¯µµÃ¼´Â À̵éÀÇ Ç׿° ÀÛ¿ë¿¡ µµ¿òÀÌ µÇµµ·Ï À̵éÀÇ ÇÇÁö È£¸£¸ó ¿µÇâÀ» ¾ïÁ¦½ÃÅ°±â À§ÇØ º¯ÇüµÇ¸ç ±×°ÍÀº È£¸£¸ó ÀÛ¿ëÀ¸·Î °£ÁÖµÉ °ÍÀÌ´Ù. À̰͵éÀº ÁÖ·Î ÄÚ¸£Æ¼¼Õ(cortisone)((INN)¡¤È÷µå·ÎÄÚ¸£Æ¼¼Õ(hydrocortisone)(INN)¡¤ÇÁ·¹µå´Ï¼Õ(prednisone)(INN)°ú ÇÁ·¹µå´Ï¼Ö·Ð(prednisolone)(INN)ÀÇ À¯µµÃ¼µéÀÌ´Ù. À̰͵éÀº Ç׿°°ú Ç×·ù¸ÓƼÁòÁ¦·Î »ç¿ëÇÑ´Ù. (2) ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀ̵å(corticosteroid) È£¸£¸óÀÇ ÇҷΰÕÈ À¯µµÃ¼ : ÀϹÝÀûÀ¸·Î °í³ ¸µ(gonane ring)ÀÇ 6 À̳ª 9 À§Ä¡¿¡¼ ¼ö¼Ò¿øÀÚ´Â ¿°¼Ò³ª ºÒ¼Ò ¿øÀÚ[¿¹¸¦ µé¸é, µ¦»ç¸ÞŸÁ¸(dexamethasone)(INN)]¿¡ ÀÇÇؼ ´ëüµÇ°í ´çÁú ºÎ½ÅÇÇÁúÈ£¸£¸ó(ÄÚ¸£Æ¼ÄÚÀ̵å)°ú À̰͵鿡¼ À¯µµµÈ ÄÚ¸£Æ¼ÄÚÀ̵åÀÇ ¼Ò¿°ÀÛ¿ëÀ» Å©°Ô ³ôÀÌ´Â ½ºÅ×·ÎÀ̵åÀÌ´Ù. ÀÌ À¯µµÃ¼µéÀº ¿¡½ºÅ׸£¿Í ¾Æ¼¼Å䳪À̵å[¿¹¸¦ µé¸é, Ç÷ç¿À½Ã³ë·Ð ¾Æ¼¼Åä´Ïµå(fluocinolone acetonide)(INN)] µîÀÇ ÇüÅ·ΠÁ¾Á¾ ´õ º¯ÇüµÇ¾î ÆǸŵȴÙ. (3) ¿¡½ºÆ®·Î°Õ(oestrogens)°ú ÇÁ·Î°Ô½ºÅä°Õ(progestogens) : À̵éÀº ³²¼º°ú ¿©¼º »ý½Ä±âµé¿¡ ÀÇÇؼ ºÐºñµÇ´Â ¼º È£¸£¸óµé ÁßÀÇ ÁÖ¿äÇÑ µÎ ±×·ìÀÌ´Ù. À̰͵éÀº ÇÕ¼ºÇÔÀ¸·Î½á ¾òÀ» ¼ö ÀÖ´Ù. ÀÌ È£¸£¸óÀº ÇÁ·Î°Ô½ºÆ¾°ú °Ô½ºÅ¸°ÕÀ¸·Î ºÒ¸°´Ù. ¿¡½ºÆ®·Î°Õ(oestrogens) : ³¼Ò¡¤°íȯ¡¤ºÎ½Å¡¤ÅÂ¹Ý ±×¸®°í ´Ù¸¥ ½ºÅ×·ÎÀ̵带 »ý¼ºÇÏ´Â Á¶Á÷µé¿¡ ÀÇÇؼ »ý¼ºµÇ´Â ¿©¼º È£¸£¸óÀÌ´Ù. ±×°ÍÀº ¾ÏÄÆ Æ÷À¯µ¿¹°¿¡¼ ¹ßÁ¤Çϵµ·Ï Çϴ Ư¡ÀÌ ÀÖ´Ù. ¿¡½ºÆ®·Î°ÕÀº ¿©¼º¼ºµéÀÌ ¹ßÇöµÇ°Ô ÇÏ°í Æó°æ±â Ä¡·áÁ¦³ª ÇÇÀÓ¾àÀÇ Á¶Á÷Ç¥º»À¸·Î »ç¿ëÇÑ´Ù. À̰͵éÀº ¾Æ·¡ÀÇ ¿¡½ºÆ®·Î°Õ¡¤À¯µµÃ¼ ±×¸®°í À¯»çü¸¦ Æ÷ÇÔÇÑ´Ù. (a) ¿¡½ºÆ®·Ð(estrone)(INN) : Àΰ£ÀÇ ÁÖ¿äÇÑ ¿¡½ºÆ®·Î°Õ (b) ¿¡½ºÆ®¶óµð¿Ã(estradiol)(INN) : Áß¿äÇÑ Ãµ¿¬ ¿¡½ºÆ®·Î°Õ (c) ¿¡½ºÆ®¸®¿Ã(estriol)(INN) : ÀÚ¿¬ ¿¡½ºÆ®·Î°Õ (d) ¿¡Æ¼´Ò ¿¡½ºÆ®¶óµð¿Ã(ethinyl estradiol)(INN) : ÀÔÀ» ÅëÇؼ È°µ¿¼ºÀÌ ÀÖ°í Á¶ÇÕ ±¸° ÇÇÀӾ࿡¼ ÁÖ¿ä ¿¡½ºÆ®·Î°Õ ¼ººÐÀ¸·Î »ç¿ëÇÏ´Â Áß¿äÇÑ ÇÕ¼º ¿¡½ºÆ®·Î°Õ (e) ¸Þ½ºÆ®¶ó³î(mestranol)(INN) : ¿¡Æ¼´Ò ¿¡½ºÆ®¶óµð¿Ã(ethinyl estradiol)ÀÇ ¿¡Å׸£(ethers) À¯µµÃ¼. ±¸° ÇÇÀÓ¾àÀ¸·Î »ç¿ëÇÑ´Ù. ÇÁ·Î°Ô½ºÅä°Õ(progestogens) : ±×°ÍµéÀÇ ÀÓ½ÅÀüÀÇ È¿°ú¸¦ °í·ÁÇÏ¿© ¸í¸íµÈ ½ºÅ×·ÎÀ̵åµé ÁßÀÇ ÇÑ Á¾·ùÀε¥, ±×°ÍÀº ÀÓ½ÅÀ» ½ÃÀÛÇÏ°Ô ÇÏ°í Áö¼Ó½ÃÅ°´Âµ¥ ÇʼöÀûÀÌ´Ù. ÀÌ ¿©¼º È£¸£¸óµéÀº ÀÓ½ÅÀ» À§ÇÏ¿© ±×¸®°í ÀÓ½ÅÀ» Áö¼Ó½ÃÅ°±â À§ÇÏ¿© ÀÚ±ÃÀ» Áغñ½ÃŲ´Ù. ±×°ÍµéÀº ¹è¶õÀ» ¸·±â ¶§¹®¿¡, ¸¹Àº ÇÁ·ÎÁ¦½ºÆ¾ÀÌ ÇÇÀÓ¾àÀÇ ¼ººÐµé·Î¼ »ç¿ëÇÑ´Ù. À̰͵éÀº ´ÙÀ½À» Æ÷ÇÔÇÑ´Ù. (a) ÇÁ·Î°Ô½ºÅ×·Ð(progesterone)(INN)* : ü³»ÀÇ Á¦1±â ÇÁ·Î°Ô½ºÆ¾ÀÌ¸ç ¿¡½ºÆ®·Î°Õ¡¤¾Èµå·Î°Õ°ú ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀ̵å(corticosteroid)ÀÇ »ýÈÇÕ °úÁ¤¿¡¼ÀÇ Áß°£¹°. ±×°ÍÀº ³ÀÚ ¹æÃâ ÈÄ È²»öü¿¡ ÀÇÇؼ »ý¼ºµÇ°í ºÎ½Å¡¤Å¹ݡ¤°íȯ¿¡¼ »ý¼ºµÈ´Ù. (b) ÇÁ·¹±×³µð¿Ã(pregnandiol) : ÇÁ·Î°Ô½ºÅ׷к¸´Ù ÈξÀ ´õ ¾àÇÑ »ý¹°ÇÐÀû È°¼ºµµ¸¦ °®°í Àִ õ¿¬ÀûÀ¸·Î »ý±â´Â ÇÁ·Î°Ô½ºÆ¾ (4) ±× ¹ÛÀÇ ½ºÅ×·ÎÀ̵å È£¸£¸ó ¾Èµå·Î°Õ(androgens) : À§¿¡ Æ÷ÇÔµÇÁö ¾ÊÀº ¼ºÈ£¸£¸óÀÇ Áß¿äÇÑ ±×·ìÀ̸ç ÁÖ·Î °íȯ¿¡¼ »ý¼ºµÇ¸ç ³¼Ò, ºÎ½ÅÇÇÁú°ú Źݿ¡¼ ÀûÀº ¾çÀÌ »ý¼ºµÈ´Ù. ¾Èµå·Î°ÕÀº ³²¼º ¼ºÀ» Çü¼ºÇÏ´Â ¿ªÇÒÀ» ÇÑ´Ù. ¾Èµå·Î°ÕÀº ½ÅÁø´ë»ç µî¿¡ ¿µÇâÀ» ¹ÌÄ¡¸ç µ¿ÈÀÛ¿ëÀ» ÇÑ´Ù. Å×½ºÅ佺Å×·Ð(testosterone) (INN)Àº °¡Àå Áß¿äÇÑ ¾Èµå·Î°Õµé Áß ÇϳªÀÌ´Ù. ÀÌ ºÎºÐÀº ¶ÇÇÑ Ç׿¡½ºÆ®·Î°Õ¡¤Ç׾ȵå·Î°Õ°ú Ç×ÇÁ·Î°Ô½ºÅ×·Ð(Ç×ÇÁ·Î°Ô½ºÆ¾¡¤Ç׿¡½ºÅ¸°Õ)°ú °°Àº È£¸£¸óÀÇ ¿µÇâÀ» ¾ïÁ¦Çϰųª ¹æÇØÇϴµ¥ »ç¿ëÇÏ´Â ÇÕ¼º ½ºÅ×·ÎÀ̵åµéÀ» Æ÷ÇÔÇÑ´Ù. ½ºÅ×·ÎÀ̵å Ç×ÇÁ·Î°Ô½ºÆ¾Àº ¸î¸îÀÇ ´ç´¢º´ Ä¡·á¿¡ ¸¹ÀÌ »ç¿ëÇÏ´Â ÇÁ·Î°Ô½ºÆ¾ ±æÇ×Á¦ÀÌ´Ù. ¿¹¸¦ µé¸é, ÀÌ ±×·ì¿¡´Â ¿À³ªÇÁ¸®½ºÅæ(onapristone)(INN)°ú ¾Æ±Û·¹ÇÁ¸®½ºÅæ(aglepristone)(INN)À» Æ÷ÇÔÇÑ´Ù. ÀÌµé ½ºÅ×·ÎÀ̵å Áß ±¹Á¦¹«¿ª»ó Áß¿äÇÑ °ÍÀº ´ÙÀ½ Ç¥¿Í °°´Ù. º» Ç¥´Â ±× ¹°Ç°ÀÇ ¾à¸íÀ» ¾ËÆĺª¼øÀ¸·Î ±âÀçÇÏ¿´°í ±× ÁÖµÈ È£¸£¸ó ÀÛ¿ëÀ» Ç¥½ÃÇÏ¿´´Ù. »ç¿ëÇÑ Ç°¸íÀº WHO¿¡¼ °øÇ¥ÇÑ International Nonproprietary Names for pharmaceutical preparations(INN)³ª International Nonproprietary Names Modified(INNM)¿¡ ÀÇÇÏ¿´À¸¸ç, ÈÇиíÀº IUPACÀÇ 1957³â ½ºÅ×·ÎÀ̵å Ç°¸ñºÐ·ù±ÔÁ¦¿¡ ÀÇÇÑ °ÍÀÌ´Ù.
ÁַΠȣ¸£¸ó ±â´ÉÀ¸·Î »ç¿ëÇÏ´Â ½ºÅ×·ÎÀ̵åÀÇ À϶÷Ç¥ ¾à¸í / ÈÇиí / ÁÖÈ£¸£¸ó±â´É Adrenosterone / androst-4-ene-3,11,17-trione / Androgen Aldosterone (INN) / 11¥â,21-dihydroxy-3,20-dioxopregn-4-en-18-al / Corticosteroid Allylestrenol (INN) / 17¥á-allyloestr-4-en-17¥â-ol / Progestogen (No short name) / 5¥á-androstane-3,17-dione / Androgen intermediate Androstanolone (INN) / 17¥â-hydroxy-5¥á-androstan-3-one / Androgen Androstenediols / androst-5-ene-3¥â,17¥â-diol, androst-5-ene-3¥â,17¥â-diol / Anabolic intermediate (No short name) / androst-4-ene-3,17-dione / Androgen intermediate Androsterone / 3¥á-hydroxy-5a-androstan-17-one / Androgen Betamethasone (INN) / 9¥á-fluoro-11¥â,17a,21-trihydroxy-16¥â-methylpregna-1,4-diene-3,20-dione / Corticosteroid Bolasterone (INN) / 17¥â-hydroxy-7¥á,17¥á-dimethylandrost-4-en-3-one / Anabolic Chlormadinone (INN) / 6-chloro-17¥á-hydroxypregna-4,6-diene-3,20-dione / Progestogen Chloroprednisone (INN) / 6¥á-chloro-17¥á,21-dihydroxypregna-1,4-diene-3,11,20-trione / Corticosteroid Clocortolone (INN) / 9¥á-chloro-6¥á-fluoro-11¥â,21-dihydroxy-16¥á-methylpregna-1,4-diene-3,20-dione / Corticosteroid Clostebol (INN) / 4-chloro-17¥â-hydroxyandrost-4-en-3-one / Anabolic Corticosterone / 11¥â,21-dihydroxypregn-4-ene-3,20-dione / Corticosteroid Cortisol - see Hydrocortisone Cortisone (INN) / 17¥á,21-dihydroxypregn-4-ene-3,11,20-trione / Corticosteroid 11-Dehydrocorticosterone / 21-hydroxypregn-4-ene-3,11,20-trione / Corticosteroid Deoxycorticosterone - see Desoxycortone Desoxycortone (INN) / 21-hydroxypregn-4-ene-3,20-dione / Corticosteroid Dexamethasone (INN) / 9¥á-fluoro-11¥â,17¥á,21-trihydroxy-16¥á-methylpregna-1,4-diene-3,20-dione / Corticosteroid Dihydroandrosterone / 5¥á-androstane-3¥á,17¥â-diol / Androgen intermediate Dydrogesterone (INN) / 9¥â,10¥á-pregna-4,6-diene-3,20-dione / Progestogen Equilenin / 3-hydroxyoestra-1,3,5(10),6,8-pentaen-17-one / Oestrogen Equilin / 3-hydroxyoestra-1,3,5(10),7-tetraen-17-one /Oestrogen / Estradiol (INN) / oestra-1,3,5(10)-triene-3,17¥â-diol / Oestrogen Estriol (INNM) / oestra-1,3,5(10)-triene-3,16¥á,17¥â-triol / Oestrogen Estrone (INN) / 3-hydroxyoestra-1,3,5(10)-trien-17-one / Oestrogen Ethinylestradiol (INN) / 17¥á-ethynyloestra-1,3,5(10)-triene-3,17¥â-diol / Oestrogen Ethisterone (INN) / 17¥á-ethynyl-17¥â-hydroxyandrost-4-en-3-one / Progestogen Ethylestrenol (INN) / 17¥á-ethyloestr-4-en-17¥â-ol / Anabolic Etynodiol (INN) / 17¥á-ethynyloestr-4-ene-3¥â,17¥â-diol / Progestogen Fludrocortisone (INN) / 9¥á-fluoro-11¥â,17¥á,21-trihydroxypregn-4-ene-3,20-dione/ Corticosteroid / Flumetasone (INN) / 6¥á,9¥á-difluoro-11¥â,17¥á,21-trihydroxy-16¥á-methylpregna-1,4-diene- 3,20-dione / Corticosteroid Fluocinolone (INNM) / 6¥á,9¥á-difluoro-11¥â,16¥á,17¥á,21-tetrahydroxy-pregna-1,4-diene-3,20-dione / Corticosteroid Fluocortolone (INN) / 6¥á-fluoro-11¥â,21-dihydroxy-16¥á-methylpregna-1,4-diene-3,20-dione / Corticosteroid Fluorometholone (INN) / 9¥á-fluoro-11¥â,17¥á-dihydroxy-6¥á-methylpregna-1,4-diene-3,20-dione / Corticosteroid 9¥á-Fluoroprednisolone / 9¥á-fluoro-11¥â,17¥á,21-trihydroxypregna-1,4-diene-3,20-dione / Corticosteroid Fluoxymesterone (INN) / 9¥á-fluoro-11¥â,17¥â-dihydroxy-17¥á-methylandrost-4-en-3-one / Androgen Fluprednidene (INN) / 9¥á-fluoro-11¥â,17¥á,21-trihydroxy-16-methylenepregna-1,4-diene-3,20-dione / Corticosteroid Fluprednisolone (INN) / 6¥á-fluoro-11¥â,17¥á,21-trihydroxypregna-1,4-diene-3,20-dione / Corticosteroid Flurandrenolone / 6¥á-fluoro-11¥â,16¥á,17¥á,21-tetrahydroxypregn-4-ene-3,20-dione / Corticosteroid Formocortal (INN) / 3-(2-chloroethoxy)-9¥á-fluoro-6-formyl-11¥â,21-dihydroxy-16¥á,17-isopropylidenedioxypregna-3,5-dien-20 one 21-acetate / Corticosteroid Gestonorone (INNM) / 17¥â-ethyl-17¥á-hydroxyoestr-4-ene-3,20-dione / Progestogen Hydrocortisone (INN) / 11¥â,17¥á,21-trihydroxypregn-4-ene-3,20-dione / Corticosteroid Hydroxyprogesterone (INN) / 17¥á-hydroxypregn-4-ene-3,20-dione / Progestogen Lynestrenol (INN) / 17¥á-ethynyloestr-4-en-17¥â-ol / Progestogen Medroxyprogesterone (INN) / 17¥á-hydroxy-6¥á-methylpregn-4-ene-3,20-dione / Progestogen Megestrol (INN) / 17¥á-hydroxy-6-methylpregna-4,6-diene-3,20-dione / Progestogen Mestanolone (INN) / 17¥â-hydroxy-17¥á-methyl-5¥á-androstan-3-one / Anabolic Mesterolone (INN) / 17¥â-hydroxy-1¥á-methyl-5¥á-androstan-3-one / Androgen Mestranol (INN) / 17¥á-ethynyl-3-methoxyoestra-1,3,5(10)-trien-17¥â-ol / Oestrogen Metandienone (INN) / 17¥â-hydroxy-17¥á-methylandrosta-1,4-dien-3-one / Anabolic Metenolone (INN) / 17¥â-hydroxy-1-methyl-5¥á-androst-1-en-3-one / Anabolic Methandriol (INN) / 17¥á-methylandrost-5-ene-3¥â,17¥â-diol / Anabolic 2-Methylhydrocortisone / 11¥â,17¥á,21-trihydroxy-2¥â-methylpregn-4-ene-3,20-dione / Corticosteroid 6¥á-Methylhydrocortisone / 11¥â,17¥á,21-trihydroxy-6¥á-methylpregn-4-ene-3,20-dione / Corticosteroid Methylnortestosterone / 17¥â-hydroxy-17¥á-methyloestr-4-en-3-one / Progestogen 17¥á-Methyloestradiol / 17¥á-methyloestra-1,3,5(10)-triene-3,17¥â-diol / Oestrogen Methylprednisolone (INN) / 11¥â,17¥á,21-trihydroxy-6¥á-methylpregna-1,4-diene-3,20-dione / Corticosteroid Methyltestosterone (INN) / 17¥â-hydroxy-17¥á-methylandrost-4-en-3-one / Androgen Nandrolone (INN) / 17¥â-hydroxyoestr-4-en-3-one / Anabolic Norethandrolone (INN) / 17¥á-ethyl-17¥â-hydroxyoestr-4-en-3-one / Anabolic Norethisterone (INN) / 17¥á-ethynyl-17¥â-hydroxyoestr-4-en-3-one / Progestogen Noretynodrel (INN) / 17¥á-ethynyl-17¥â-hydroxyoestr-5(10)-en-3-one / Progestogen Norgestrel (INN) / 13¥â-ethyl-17¥á-ethynyl-17¥â-hydroxygon-4-en-3-one / Progestogen Normethandrone - see Methylnortestosterone Nortestosterone - see Nandrolone Oxabolone (INNM) / 4,17¥â-dihydroxyoestr-4-en-3-one / Anabolic Oxymesterone (INN) / 4,17¥â-dihydroxy-17¥á-methylandrost-4-en-3-one / Anabolic Oxymetholone (INN) / 17¥â-hydroxy-2-hydroxymethylene-17¥á-methyl-5¥á-androstan-3-one / Anabolic Paramethasone (INN) / 6¥á-fluoro-11¥â,17¥á,21-trihydroxy-16¥á-methylpregna-1,4-diene-3,20-dione / Corticosteroid Prasterone (INN) / 3¥â-hydroxyandrost-5-en-17-one / Androgen Prednisolone (INN) / 11¥â,17¥á,21-trihydroxypregna-1,4-diene-3,20-dione / Corticosteroid Prednisone (INN) / 17¥á,21-dihydroxypregna-1,4-diene-3,11,20-trione / Corticosteroid Prednylidene (INN) / 11¥â,17¥á,21-trihydroxy-16-methylenepregna-1,4-diene-3,20-dione / Corticosteroid Pregnenolone (INN) / 3¥â-hydroxypregn-5-en-20-one / Corticosteroid Progesterone (INN) / pregn-4-ene-3,20-dione / Progestogen Stanolone - see Androstanolone Testosterone (INN) / 17¥â-hydroxyandrost-4-en-3-one / Androgen Tiomesterone (INN) / 1¥á,7¥á-di(acetylthio)-17¥â-hydroxy-17¥á-methylandrost-4-en-3-one / Anabolic Triamcinolone (INN) / 9¥á-fluoro-11¥â,16¥á,17¥á,21-tetrahydroxypregna-1,4-diene-3,20-dione / Corticosteroid (C) ÇÁ·Î½ºÅ¸±Û¶õµò(prostaglandins), Æ®·Òº¹»ê(thromboxanes) ±×¸®°í ·ùÄÚÆ®¸®¿£(leukotrienes)¡¤±× À¯µµÃ¼¿Í ±¸Á¶Àû À¯»çü ÀÌ »ý¼º¹°µéÀº ¾Æ¶óÅ°µ·»ê(arachidonic acid)ÀÇ À¯µµÃ¼´Ù. (1) ÇÁ·Î½ºÅ¸±Û¶õµò(prostaglandins) °¡Àå Áß¿äÇÑ ¾Æ¶óÅ°µ·»ê(arachidonic acid) À¯µµÃ¼´Â È£¸£¸óÀ¸·Î¼ ¹Ì¼Ò·®¿¡¼µµ ÀÛ¿ëÇÏ´Â ±×¸®°í ÇÁ·Î½ºÅ¸³ë»êÀÇ ±âº»ÀûÀÎ ±¸Á¶¸¦ Æ÷ÇÔÇÏ´Â ³»»ýÀû ¹°ÁúÀÎ ÇÁ·Î½ºÅ¸±Û¶õµò(prostaglandins)ÀÌ´Ù. ÇÁ·Î½ºÅ¸±Û¶õµòÀº Ç÷¾× ¼øȯ¡¤ÄáÆÏ ±â´É ±×¸®°í ¿£µå·ÎÅ©¸°(endrocrine) ü°è[¿¹¸¦ µé¸é Ȳü(üÜô÷)¿¡ ÀÇÇÑ ÇÁ·Î°Ô½ºÅ×·ÐÀÇ »ý¼ºÀ» ÁÙÀÓÀ¸·Î½á]ÀÇ Á¶Àý¿¡ ¿µÇâÀ» ³¢Ä¡¸ç; À̰͵éÀº ¶ÇÇÑ À¯¿¬ÇÑ ±ÙÀ°ÀÇ ¼öÃà ȤÀº Ç÷°üÀÇ È®ÀåÀ» ÀÚ±ØÇÏ°í Ç÷¼ÒÆÇ ÀÀÁýÀ» ¸·À¸¸ç À§¼±ºÐºñ¸¦ Á¶ÀýÇÑ´Ù. À̰͵éÀº ¾Æ·¡ÀÇ ÇÁ·Î½ºÅ¸±Û¶õµò¡¤À¯µµÃ¼ ±×¸®°í ±¸Á¶Àû À¯»çü¸¦ Æ÷ÇÔÇÑ´Ù. (a) ¾ËÇÁ·Î½ºÅ¸µô(alprostadil)(INN)(ÇÁ·Î½ºÅ¸±Û¶õµò E1) : »ý¹°ÇÐÀû ÃßÃâ¹°(extract) µî¿¡¼ °áÁ¤ÈµÈ 1±â ÇÁ·Î½ºÅ¸±Û¶õµòÀÌ´Ù. ÀÌ°ÍÀº Ç÷°üÈ®ÀåÁ¦·Î »ç¿ëÇÑ´Ù. ÀÌ°ÍÀº ¶ÇÇÑ ÄáÆÏ ²®Áú¿¡¼ ¿¡¸®Æ®·ÎÆ÷¿¡Æ¾ÀÇ ¹æÃâÀ» ÀÚ±ØÇÏ´Â ±â´ÉÀ» ÇÏ°í Ç÷¾× Ç÷¼ÒÆÇ ÀÀÁýÀ» ¾ïÁ¦ÇÑ´Ù. (b) ¾ËÆÄÇÁ·Î½ºÅç(alfaprostol)(INN). ´ç³ª±Í¡¤³ë»õ µîÀÇ ¾ÏÄƵéÀÇ ºÒÀÓÁõ Ä¡·á¿¡ »ç¿ëÇÏ´Â ÇÕ¼º ÇÁ·Î½ºÅ¸±Û¶õµò À¯»çü (c) Æ¿¼öÇÁ·Î½ºÆ®(tilsuprost)(INN). ¸µ Æó¼â(ring closure)¿Í ÇÔ²² Áú¼Ò¿Í Ȳ ¿øÀÚ¿¡ ÀÇÇØ ´ëüµÈ »ê¼Ò¿Í ź¼Ò ¿øÀÚ¸¦ °¡Áø ÇÁ·Î½ºÅ¸±Û¶õµò À¯»çü ÀÌ ±×·ìÀº ÇÁ·Î½ºÅ»·»(prostalene)(INN)¡¤´ÙÀ̳ëÇÁ·Î½ºÆ®(dinoprost)(INN) °°Àº ´Ù¸¥ ÇÕ¼º »ý¼º¹°µéµµ Æ÷ÇÔÇϴµ¥, ±×°ÍÀº ÀÚ¿¬ÀûÀÎ »ý¼º¹°µéÀÇ ±âº»ÀûÀÎ ±¸Á¶¸¦ º¸À¯ÇÏ°í ºñ½ÁÇÑ »ý¸®ÇÐÀû È°¼ºµµ¸¦ °¡Áö°í ÀÖ´Ù. (2) Æ®·Òº¹»ê(thromboxanes)°ú ·ùÄÚÆ®¸®¿£(leukotrienes) Æ®·Òº¹»ê°ú ·ùÄÚÆ®¸®¿£Àº ÇÁ·Î½ºÅ¸±Û¶õµòó·³ ¾Æ¶óÅ°µ·»ê¿¡ ÀÇÇØ ¼¼Æ÷ ³»¿¡¼ ÇÕ¼ºµÇ¸ç; À̵éÀÇ ±â´ÉÀº ÇÁ·Î½ºÅ¸±Û¶õµò(prostaglandins)°ú ºñ½ÁÇÏ°í À̵éÀÇ ±¸Á¶µµ ¸Å¿ì ºñ½ÁÇÏÁö¸¸, ÇÁ·Î½ºÅº »êÀÇ ±âº»ÀûÀÎ ±¸Á¶¸¦ Æ÷ÇÔÇÏÁö ¾Ê´Â´Ù. Æ®·Òº¹»êÀº »ýÇÕ¼ºÀûÀ¸·Î ÇÁ·Î½ºÅ¸±Û¶õµò¿¡¼ À¯µµµÈ´Ù. À̵éÀº Ç÷¼ÒÆÇ ÀÀÁý°ú µ¿¸ÆÀÇ ¼öÃàÀ» ¾ß±âÇÏ°í ´ÙºÒÆ÷È Áö¹æ»ê ÀÛ¿ëÀÇ Áß¿äÇÑ Á¶Àý ÀÎÀÚÀÌ´Ù. ·ùÄÚÆ®¸®¿£Àº ¹éÇ÷±¸ ³»¿¡¼ÀÇ »ý¼º°ú À̵éÀÇ º¹ÇÕÀûÀÎ Æ®¸®¿£ ±¸Á¶·Î ÀÎÇØ ±×·¸°Ô ¸í¸íµÇ¾ú´Ù. À̵éÀº È¿´ÉÀÌ ÀÖ´Â ±â°üÁö ¼öÃàÁ¦ÀÌ°í °ú¹Î¼º ¹ÝÀÀ¿¡¼ Áß¿äÇÑ ¿ªÇÒÀ» ÇÑ´Ù. (a) Æ®·Òº¹»ê B2. Ç÷°ü¼öÃàÁ¦¡¤±â°üÁö¼öÃàÁ¦¿Í Ç÷¾× Ç÷¼ÒÆÇ ÀÀÁýÀÇ À¯¹ßÀÎÀÚ (b) ·ùÄÚÆ®¸®¿£ C4. È÷½ºÅ¸¹ÎÀ̳ª ÇÁ·Î½ºÅ¸±Û¶õµòÀÌ ÆóÀÇ ±âµµ¿¡ ÀÛ¿ëÇÏ´Â È¿°úº¸´Ù 100¹è¿¡¼ 1,000¹è ´õ È¿·ÂÀÌ ÀÖ´Â °ÍÀ¸·Î ¹àÇôÁ³´Ù. (D) ´Ù¸¥ È£¸£¸óµé ¿©±â¿¡ ºÐ·ùÇÑ °ÍµéÀº ±× ±¸Á¶°¡ À§¿¡ ¾ð±ÞµÈ È£¸£¸óµéÀÇ ±¸Á¶¿Í´Â ´Ù¸¥ ±× ¹ÛÀÇ È£¸£¸óµéÀÌ´Ù. ÇÑ ¿¹·Î ¸á¶óÅä´Ñ(melatonin)ÀÌ Àִµ¥, ±×°ÍÀº ¼Û°ú¼±(áæÍýàÍ : pineal gland)¿¡¼ ¹ß°ßµÇ°í Àε¹ÀÇ À¯µµÃ¼·Î °£ÁÖµÉ ¼ö ÀÖ´Ù. ¿©±â¿¡ ºÐ·ùÇÏ´Â ±× ¹ÛÀÇ È£¸£¸óµéÀº ´ÙÀ½°ú °°´Ù. (1) Ä«Å×Äݶó¹Î(catecholamine) È£¸£¸óµé, ±× À¯µµÃ¼¿Í ±¸Á¶ÀûÀÎ À¯»çü ÀÌ È£¸£¸ó ±×·ìÀº ºÎ½Å(adrenal glands)ÀÇ ¼öÁúÃþ¿¡¼ ¹ß°ßµÇ´Â °ÍµéÀ» Æ÷ÇÔÇÑ´Ù. (a) ¿¡Çdz×ÇÁ¸°(epinephrine)(INN)(¾Æµå·¹³¯¸° ȤÀº (-)-3,4-µðÈ÷·Ï½Ã-¥á-[(¸ÞÆ¿¾Æ¹Ì³ë)¸ÞÆ¿]º¥Áú ¾ËÄÚ¿Ã)°ú ·¹½ÃÇÉÇÁ¸°(racepinephrine)(INN)((¡¾)-3,4-µðÈ÷·Ï½Ã-¥á-[(¸ÞÆ¿¾Æ¹Ì³ë)¸ÞÆ¿]º¥Áú ¾ËÄÚ¿Ã). ÀÌ µÎ È£¸£¸óµéÀÇ ±¸Á¶´Â ÈÇÐÀûÀÎ À̸§ 1-(3,4-µðÈ÷·Ï½ÃÆä´Ò)-2-¸ÞÆ¿¾Æ¹Ì³ë¿¡Åº¿Ã°ú ÀÏÄ¡ÇÑ´Ù. ¿¡Çdz×ÇÁ¸°Àº ºû¿¡ ÀÇÇؼ ¿µÇâÀ» ¹Þ´Â ¹àÀº °¥»öÀ̳ª °ÅÀÇ Èò»öÀÇ °áÁ¤¼º °¡·çÀÌ´Ù. ±×°ÍÀº ¹°°ú À¯±â ¿ëÁ¦(éÁð¥ : solvent)¿¡¼ Á¶±Ý ³ì´Â´Ù. ±×°ÍÀº ¸»ÀÇ ºÎ½Å¿¡¼ À¯µµµÉ ¼ö ÀÖÀ¸³ª ÇÕ¼º¿¡ ÀÇÇؼ ÁÖ·Î ¾ò¾îÁø´Ù. °íÇ÷¾Ð È£¸£¸óÀÌ Àִµ¥, ÀÌ°ÍÀº ±³°¨½Å°æ°è¸¦ ÀÚ±ØÇÏ°í Ç÷±¸(corpuscles)ÀÇ ¼ö¿Í Ç÷¾×¼Ó¿¡ ´çÀÇ ÇÔ·®À» Áõ°¡½ÃŲ´Ù. ÀÌ°ÍÀº °ÇÑ Ç÷°ü ¼öÃà ÀÛ¿ëÀ» ÇÑ´Ù. (b) ³ë¸£¿¡Çdz×ÇÁ¸°(norepinephrine)(INN)[(·¹¹ÙÅ×·¹³î, ³ë¸£¾Æµå·¹³¯¸° ȤÀº (-)-2-¾Æ¹Ì³ë-1-(3,4-µðÈ÷µå·Ï½ÃÆä´Ò)¿¡Åº¿Ã]. ³ë¸£¿¡Çdz×ÇÁ¸°Àº ¹°¿¡¼ ³ì´Â Èò °áÁ¤Ã¼·Î ³ªÅ¸³´Ù. ÀÌ°ÍÀÇ »ý¸®ÇÐÀû È°¼ºµµ´Â ¾Æµå·¹³¯¸°°ú ¿¡Æäµå¸° »çÀÌÀÇ Áß°£ÀÌ´Ù. (2) ¾Æ¹Ì³ë»ê À¯µµÃ¼ (a) ·¹º¸Å¸À̷ϽÅ(levothyroxine)(INNM)°ú DL-ŸÀ̷ϽÅ(3-[4-(4-È÷µå·Ï½Ã-3,5-´ÙÀÌ¿ÀµµÆä³ì½Ã(diiodophenoxy))-3,5-µð¾ÆÀÌ¿ÀµµÆä´Ò(diiodophenyl)]¾Ë¶ó´ÑÀ̳ª 3,5,3',5'-Å×Æ®¶ó¾ÆÀÌ¿ÀµµÆ¼·Î´Ñ(tetraiodothyronine). ŸÀ̷ϽÅÀº °©»ó¼±¿¡¼ ÃßÃâµÇ°Å³ª ÇÕ¼º¿¡ ÀÇÇؼ ¾ò¾îÁø´Ù. ÀÌ°ÍÀº ¹æÇ⼺(Û»úÅàõ) ¾Æ¹Ì³ë»êÀ̸ç; ¹°À̳ª ¾î¶°ÇÑ ÀϹÝÀûÀÎ ¿ëÁ¦(éÁð¥ : solvent)¿¡¼µµ ³ìÁö ¾Ê´Â Èò»öÀ̳ª ´©¸£½º¸§ÇÑ °áÁ¤Ã¼µé·Î ³ªÅ¸³´Ù. ÀÌ°ÍÀº ±âÃÊ ´ë»çÀ²°ú »ê¼Ò ¼Ò¸ð¸¦ Áõ°¡½ÃÅ°°í ±³°¨ ½Å°æ°è¸¦ ¿òÁ÷ÀÌ°í ´Ü¹éÁú°ú Áö¹æÀÇ ÀÛ¿ëÀ» Á¶ÀýÇϸç À¯±âüÀÇ ¸ðµç ¿ä¿Àµå °áÇÌÀ» º¸ÃæÇÏ¸ç °©»ó¼±Á¾°ú Å©·¹Æ¾ º´À» Ä¡·áÇϱâ À§ÇÏ¿© »ç¿ëÇÑ´Ù. L-À̼ºÃ¼´Â È°¼ºÃ¼ÀÌ´Ù. ³ªÆ®·ý ½Ä¿°Àº À¯»çÇÑ È°¼ºµµ¸¦ °®°í ¹°¿¡ Á¶±Ý ³ì´Â Èò °¡·çÀÌ´Ù. (b) ¸®¿ÀŸÀ̷δÑ(liothyronine)(INN)°ú ·¡½ÃŸÀ̷δÑ(rathyronine)(INN) (DL-3,5,3'-Æ®¸®¿ä¿ÀµåŸÀ̷δÑ)(3-[4-(4-È÷µå·Ï½Ã-3ÀÌ¿ÀµµÆä³ì½Ã-3,5-´ÙÀ̾ÆÀÌ¿ÀµµÆä´Ò]¾Ë¶ó´Ñ)(DL-3,5,3'-triiodothyronine)(3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]alanine). Æ®¸®¾ÆÀÌ¿ÀµåŸÀ̷δÑÀº °©»ó¼±¿¡¼µµ ÃßÃâµÇ¸ç; ÀÌ°ÍÀÇ »ý¸®ÇлóÀÇ È°¼ºµµ´Â ŸÀ̷Ͻź¸´Ùµµ ´õ Å©´Ù. Á¦¿Ü±ÔÁ¤ ÀÌ È£¿¡¼´Â ´ÙÀ½ÀÇ ¹°Ç°À» Á¦¿ÜÇÑ´Ù.(1) È£¸£¸ó È¿°ú´Â ¾øÁö¸¸ È£¸£¸ó°ú °°Àº ±¸Á¶¸¦ °®°í ÀÖ´Â ¹°Ç° (a) ¾Èµå·Î½ºÆ®-5-¿£-3 ¾ËÆÄ,17¾ËÆÄ-µð¿Ã,¾Èµå·Î½ºÆ®-5-¿£-3 ¾ËÆÄ,17º£Å¸-µð¿Ã(Á¦2906È£)°ú À̵éÀÇ µð¾Æ¼¼Å×ÀÌÆ®(Á¦2915È£) (b) ¾Æµå·¹³ª·Ð(INN)(3,'4'-µðÈ÷µå·Ï½Ã-2-¸ÞÆ¿¾Æ¹Ì³ë¾Æ¼¼ÅäÆä³í)(Á¦2922È£) (c) Á¦2922È£¿¡ ºÐ·ùÇÏ´Â ´ÙÀ½ÀÇ ¹°Ç° (¥°) 2-¾Æ¹Ì³ë-1-(3,4-µðÈ÷µå·Ï½ÃÆä´Ò)ºÎź-1-¿Ã (¥±) ÄÚ¸£¹Ùµå¸°(corbadrine)(INN)(2-¾Æ¹Ì³ë-1-(3,4-µðÇÏÀ̵å·Ï½ÃÆä´Ò) ÇÁ·ÎÆÇ-1-¿Ã¡¤3,4-µðÇÏÀ̵å·Ï½Ã³ëÆäµå¸°¡¤È£¸ð-¾Æ¸£Å×·¹³î (¥²)µ¥¿Á½Ã¿¡Çdz×ÇÁ¸°(µ¥¿Á½Ã¾Æµå·¹³¯¸°¡¤1-(3,4µðÇÏÀ̵å·Ï½ÃÆä´Ò)-2-¸ÞÆ¿¾Æ¹Ì³ë¿¡Åº¡¤¿¡ÇÇ´Ñ) (¥³) 3',4'-µðÇÏÀ̵å·Ï½Ã-2-¿¡Æ¿¾Æ¹Ì³ë ¾Æ¼¼ÅäÆä³í(4-¿¡Æ¿¾Æ¹Ì³ë ¾Æ¼¼Æ¿ Ä«Å×ÄÝ) (¥´) 1-(3,4-µðÇÏÀ̵å·Ï½ÃÆä´Ò)-2-¸ÞÆ¿¾Æ¹Ì³ëÇÁ·ÎÆÇ-1-¿Ã-(3,4-´ÙÇÏÀ̵å·Ï½Ã ¿¡Æäµå¸°) (vi) (¡¾)-¿£-¸ÞÆ¿¿¡Çdz×ÇÁ¸°((¡¾)-1-(3,4-µðÇÏÀ̵å·Ï½ÃÆä´Ò)-2-µð¸ÞÆ¿ ¾Æ¹Ì³ë¿¡Åº¿Ã¡¤¸ÞŸµå·£¡¤(¡¾)¿£-¸ÞÆ¿ ¾Æµå·¹³¯¸°) (2) È£¸£¸ó È¿°ú´Â ÀÖÁö¸¸ È£¸£¸ó ±¸Á¶¸¦ °®Áö ¾Ê´Â ¹°Ç° (a) µð¿£½ºÆ®·Ñ(dienestrol)(INN)(3,4-ºñ½º(¥ñ-È÷µå·Ï½ÃÆä´Ò) Çí»ç-2, 4-µð¿£(Á¦2907È£) (b) Çí¼¼½ºÆ®·Ñ(hexestrol)(INN)(3,4-ºñ½º(¥ñ-È÷µå·Ï½ÃÆä´Ò) Çí»ê((Á¦2907È£) (c) µð¿¡Æ¿½ºÆ¿º£½ºÆ®·Ñ(diethylstilbestrol)(INN) (Æ®·£½º-3,4-ºñ½º(¥ñ-ÇÏÀ̵å·Ï½ÃÆä´Ò)Çí½º-3-¿£) (Á¦2907È£)¿Í ±× µð¸ÞÆ¿¿¡Å׸£(dimethyl ethers)(Á¦2909È£)¡¤±× µðÇÁ·ÎÇÇ¿À³×ÀÌÆ®(Á¦2915È£)¡¤±× Ǫ·Î¿¡ÀÌÆ®(Á¦2932È£) (d) Ŭ·Î¹ÌÆæ(clomifene)(INN)(Ç׿¡½ºÆ®·Î°Õ)(Á¦2922È£) (e) Ÿ¸ñ½ÃÆæ(tamoxifen)(INN)(Ç׿¡½ºÆ®·Î°Õ)(Á¦2922È£) (f) Ç÷矹̵å(flutamide)(INN)(Ç׾ȵå·Î°Õ)(Á¦2924È£) (g) ´Ù·ç¼¾Åº(darusentan)(INN)°ú °°Àº ¿£µµÅ׸° ±æÇ×Á¦(Á¦2933È£), ¾ÆÆ®¶ó¼¾Åº(INN)(Á¦2934È£)¿Í ½ÃŸ½ëź(INN)(Á¦2935È£) (3) È£¸£¸ó È¿°ú¸¦ °®´Â õ¿¬¹°ÁúÀÌÁö¸¸ »ç¶÷°ú µ¿¹°ÀÇ Ã¼³»¿¡¼ ºÐºñµÇÁö ¾Ê´Â ¹°Áú (a) Á¦¾Æ¶ó·¹³í(zearalenone)¡¤½ÅÁø´ë»çÁ¦(Á¦2932È£) (b) ¾Æ½ºÆ丱½Å(asperlicin)¡¤ÄÝ·¹½Ã½ºÅäÄû´Ñ(cholecistoquinine)(Á¦2933È£) (4) È£¸£¸óÀ¸·Î °£Áֵǰųª ÁøÁ¤ÇÑ È£¸£¸óÀÛ¿ëÀ» ÇÏÁö ¾Ê´Â ´ÙÀ½ ¹°Ç° (a) ½Ã½ºÆ¾(cystine)¡¤½Ã½ºÅ×ÀÎ(INN)¿Í À̵éÀÇ ¿°»ê¿°(Á¦2930È£) (b) ¸ÞƼ¿À´Ñ(methionine)°ú ±× Ä®½·¿°(Á¦2930È£) (c) ½Å°æÀü´Þ¹°Áú°ú ½Å°æÁ¶Àýü[¿¹: ¼¼ÇÁ¶ó³î·Ð(INN)(Á¦2914È£)¡¤µµÆĹÎ(Á¦2922È£)¡¤¾Æ¼¼Æ¿Äݸ°(Á¦2923È£)¡¤¼¼·ÎÅä´Ñ(5-ÇÏÀ̵å·Ï½ÃÆ®¸³Å¸¹ÎÀ̳ª ÇÏÀ̵å·Ï½Ã-3-(º£Å¸-¾Æ¹Ì³ëÆ¿)Àε¹)(Á¦2933È£)¡¤È÷½ºÅ¸¹Î(Á¦2933È£)¿Í °ü·Ã Á¦Ç°(¿¹: ±×µéÀÇ ¼ö¿ëü ÀÛ¿ë¹°Áú°ú ±æÇ×Á¦)] (d) ¹éÇ÷º´¾ïÁ¦ ÀÎÀÚ (Àΰ£)¼ºÀåÀÎÀÚ(growth factor) ¿¥ÇÊ·¯¹Î(INN)(Á¦2933È£)¿Í ¼¶À¯ ¾Æ¼¼Æ÷ ¼ºÀåÀÎÀÚ(growth factor) ·¹ÇÇÆÛ¹Î(INN)(Á¦2933È£) (e) ¶ó´Ïü¹Î(lanicemine)(INN)°ú °°Àº NMDA(N-¸ÞÆ¿-D-¾Æ½ºÆĸ£Æ®»ê)¼ö¿ëü ±æÇ×Á¦(Á¦2933È£)¿Í ³×º¸½ºÆ¼³Ú(INN)(Á¦2924È£) (f) ÇìÆĸ°(heparin)(Á¦3001È£) (g) º¯¼ºÇÑ ¸é¿ª¹°Ç°(Á¦3002È£) (5) õ¿¬À̳ª ÇÕ¼ºÀÇ ½Ä¹°¼ºÀåÁ¶ÀýÁ¦(¿¹: ½Ä¹°È£¸£¸ó) (A) È¥ÇյǾî ÀÖÁö ¾Ê°Å³ª ¼Ò¸Å Æ÷ÀåµÇ¾î ÀÖÁö ¾ÊÀº °æ¿ì¿¡´Â ±× ÈÇмººÐ¿¡ µû¶ó ºÐ·ùÇÑ´Ù. ¿¹: (a) ¾ËÆÄ-³ªÇÁÆ¿¾Æ¼¼Æ®»ê°ú ±× ³ªÆ®·ý¿°(Á¦2916È£) (b) 2,4-µðŬ·Î·ÎÆä³ì½Ã¾Æ¼¼Æ®»ê(2,4-µð), 2,4,5-Ƽ(ISO)(2,4,5-Æ®¸®Å¬·Î·ÎÆä³ì½Ã¾Æ¼¼Æ®»ê)°ú 4-Ŭ·Î·Î-2-¸ÞÆ¿Æä³ì½Ã¾Æ¼¼Æ®»ê(MCPA)(Á¦2918È£) (c) º£Å¸-Àε¹¸±¾Æ¼¼Æ®»ê°ú ³ªÆ®·ý¿°(Á¦2933È£) (B) Á¶Á¦µÇ°Å³ª ¼Ò¸Å Æ÷ÀåµÇ¾î ÀÖ´Â °æ¿ì¿¡´Â Á¦3808È£¿¡ ºÐ·ùÇÑ´Ù. (6) °¢°¢ÀÇ ±¸Á¶¿¡ µû¶ó ºÐ·ùÇÏ´Â Æ®·Òº¹»ê(thromboxanes)°ú ·ùÄÚÆ®¸®¿£(leukotrienes)ÀÇ ¹æÁöÁ¦[¿¹: ¼¼¶óÆ®·Î´Ù½ºÆ®(INN)(Á¦2918È£)¿Í ¸óÅÚ·çÄ«½ºÆ®(INN)(Á¦2933È£)] (7) ¾ÆŸÄû¸¶½ºÆ®(antagonists)(INN)°ú °°Àº Á¾¾ç±«»çÀÎÀÚ(TNF : tumor necrosis factor)ÀÇ ¹æÁöÁ¦(Á¦2933È£) (8) Á¦3002È£ÀÇ ¸é¿ª¹°Ç° (9) Á¦3003È£³ª Á¦3004È£¿¡ ÇØ´çÇÏ´Â ÀǾàÇ° ƯÈ÷ "¸®Å¸µå Àν¶¸°(Retard Insulin)"(¾Æ¿¬ÈÀν¶¸°¡¤ÇÁ·ÎŸ¹Î ¾Æ¿¬ÈÀν¶¸°¡¤±Û·ÎºóÀν¶¸°¡¤¾Æ¿¬È±Û·ÎºóÀν¶¸°¡¤È÷½ºÅæÀν¶¸°) [¼ÒÈ£Çؼ³] ¼ÒÈ£ Á¦2937.11È£ºÎÅÍ Á¦2937.19È£±îÁö ÀÌ ¼ÒÈ£µé¿¡´Â µÑ ÀÌ»óÀÇ ¾Æ¹Ì³ë»êÀ» ÇÔÀ¯ÇÏ´Â ÆéŸÀ̵å È£¸£¸óÀ» Æ÷ÇÔÇÑ´Ù.
|